Longeveron Inc - Tradeable Rights - August 2023
LGVNR
Get informed when a big investor buys or sells
+ FollowMarket Cap$13.76M
Close$
Share Statistics
| Market cap | $13.76 Million |
|---|---|
| Enterprise Value | $-1,143,279.00 |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | -139.95% |
|---|---|
| Return on Assets | -105.75% |
| Return on Invested Capital | -135.67% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -0.94 |
| Enterprise Value to EBIT | 0.05 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.74 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Longeveron Inc
26 employeeslongeveron llc is a leading global regenerative medicine company developing innovative cellular therapeutics for chronic life-threatening diseases. our lead investigational product candidate (lmsc) is based on a specialized cell known as...